BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or I spent 4 months reporting on the peptide BPC 157 and its unlikely journey from a research lab in post communist Croatia to today's MAHA movement. Ask me anything. : r IAmA Frontiers BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L NAME in Rats Stable Gastric Pentadecapeptide BPC 157 as Therapy After Surgical Detachment of the Quadriceps Muscle from Its Attachments for Muscle to Bone Reattachment in Rats Too often, BPC 157 gets boxed into a single use: injury recovery. Gabriel Alizaidy, MD, MS BPC 157 Benefits: How It Supports Healing and Recovery